NFKB1 and osteoarthritis: In conclusion, we identified for the first time that P-II has a therapeutic effect on osteoarthritis, and the underlying molecular mechanism may be achieved by attenuating chondrocyte pyroptosis through inhibition of the MAPK/NF-κB pathway.